Composite Materials for Bioseparation
A composite material with a crosslinked polymer core and covalently bonded uncrosslinked surface layer addresses the inefficiencies in mAb purification, achieving high recovery and effective impurity removal.
Patent Information
- Application Number
- JP2022150967
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-03-05
- Filing Date
- 2022-09-22
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2039-03-05
AI Technical Summary
Existing methods for purifying recombinant monoclonal antibodies (mAbs) are inefficient in removing a wide variety of host cell proteins (HCPs) and other impurities, requiring multiple costly and time-consuming chromatography steps that reduce product yield and stability.
A composite material comprising a porous support with a crosslinked first polymer and an uncrosslinked second polymer covalently bonded to its surface, designed to efficiently remove HCPs and DNA from protein solutions, enhancing purification efficiency.
The composite material achieves high protein recovery rates while effectively depleting DNA and HCPs, simplifying the purification process and maintaining protein integrity.
Smart Images

Figure 0007584481000001 
Figure 0007584481000002 
Figure 0007584481000003
Abstract
Description
[Technical field]
[0001] The present invention relates to composite materials useful for the purification of proteins obtained from biological feedstocks. [Background technology]
[0002] The relevance of using proteins as biopharmaceuticals in many therapeutic and diagnostic applications has been increasing over the last decades. One area of particular interest is the use of recombinant monoclonal antibodies (mAbs). Every year, an increasing number of therapeutic mAbs and their fragments are approved for the treatment of inflammatory diseases, diabetes, various cancers and hematological disorders.
[0003] The initial single dose of mAb often needs to be in the range of about 0.1-1 g per patient due to its pharmacokinetic properties, with equivalent doses administered weekly or monthly thereafter. This requires large quantities of therapeutic mAb. Thus, therapeutic mAbs must be produced on an industrial scale. mAbs are produced from biological feedstocks such as fermentation broth (filtrate) or cell culture fluid, but the expression level of secreted recombinant antibody and its impurity content vary.
[0004] To qualify as a drug product, a target protein must be essentially free of product- or process-derived impurities that are necessarily present in the cell culture supernatant or filtrate after recovery (e.g., after recovery of cells or cell debris from target protein secreted into the cell culture medium). These contaminants include recombinant host-derived proteins and nucleic acids (DNA and RNA), e.g., Chinese Hamster Ovary Host-derived Proteins (CHO-HCP) or DNA (CHO-DNA), as well as residual cell culture medium additives, including proteins added as nutrients or stabilizers (e.g., bovine serum albumin (BSA) or transferrin), salts, buffers, as well as endotoxins and pathogenic bacteria or fragments thereof.
[0005] Known methods for purifying proteins of interest include the removal of viruses, endotoxins and to some extent nucleic acids by suitable membrane filtration steps (e.g., by binding to high strength ion exchange membranes), as well as the removal of low molecular weight water-soluble contaminants in subsequent unit operations carried out in Downstream Processing (DSP). However, the complete removal of a wide variety of HCPs is a challenging task and has so far been addressed mainly by the application of multiple dedicated preparative chromatography steps.
[0006] Chromatographic purification methods used in DSP of mAb and other recombinant protein products include affinity chromatography, cation and anion exchange, hydrophobic interaction and metal chelate affinity. More recently, a variety of multi-mode and pseudo-affinity chromatography media have become available and have found applications in the respective manufacturing processes, for example for polishing the product after an ion exchange or affinity chromatography step (EP 1807205(A)). Currently applied chromatographic methods usually use two classical chromatographic approaches: one based on a continuous elution chromatographic process and the other based on the "bind-elute" concept.
[0007] The common principle of these chromatographic separation methods is that various chromatographic media The main feature of the method is that the membrane has the ability to selectively adsorb one or more components of a biological sample. Thus, unbound (or weakly bound) components are separated from (more) strongly bound components and appear in the corresponding breakthrough fraction. To be able to separate bound components from each other, the elution conditions are often adjusted by increasing or decreasing ionic strength, pH or the concentration of a specific displacer to form a continuous or stepwise gradient to obtain volumetric and time-dependent conditions that selectively desorb the individual components.
[0008] Among the available chromatographic methods, size-exclusion chromatography (SEC) is considered not useful for large-scale operation, except for polishing purposes, due to its low productivity, low resolution, and slow rate. In contrast, one of the most widely used first steps in industrial mAb chromatographic purification platforms is based on the "capture" or "bind-elute" affinity mechanism. This type of process involves binding ("capture") the target compound, while the majority of undesired products remain unbound or may be separated by a selective elution step that releases the bound impurities before or after the target. Representative examples of this type of bind-elute process include those using Protein A.
[0009] In affinity purification of mAbs, immunoglobulins bind specifically to immobilized Protein A under conditions that facilitate very strong binding of the target protein to the chromatographic material, while HCPs and most of the other impurities remain unbound. Therefore, after washing away the unbound components, the bound immunoglobulins can be released by passing an appropriate acidic buffer through the column to change the pH of each column from near neutral to somewhat acidic conditions (e.g., pH 3). In theory, the immunoglobulin product recovered after this step should be completely pure, since Protein A is highly selective and specific in binding to distinct genetically conserved structural motifs of antibody molecules. However, in the actual manufacturing process, many side effects prevent this perfect one-step purification. Among them, it has been observed that residual HCPs bind to Protein A, to the chromatographic matrix material, or even to the immunoglobulins, and are eluted at the same time. Furthermore, leakage of traces of Protein A and its degradation products may occur and may rebind to the protein of interest, especially after the rapid pH adjustment required to return to a pH range suitable for antibody stabilization. Exposure of immunoglobulins to the specific process conditions of Protein A chromatography may also promote some irreversible product loss due to intrinsic protein instability, e.g., through aggregate formation, partial proteolytic degradation, and other deleterious effects.
[0010] Therefore, additional purification steps are necessarily required to achieve the high level of purity specified for pharmaceutical antibody products. These steps, including ion exchange and various multi-mode chromatography methods, are necessary to further reduce the amount of HCPs and nucleic acids, as well as to remove protein aggregates and smaller antibody degradation products. Such purification steps cause further reduction in product yield and also add costly and time-consuming labor to the overall manufacturing process. Therefore, there is a need for a technology that can remove the majority of impurities in a single processing step.
[0011] Many methods are known that utilize composite adsorbents for the purification of mAbs and other proteins, in which the composite adsorbents are typically packed into a chromatography column.
[0012] WO 95 / 025574 discloses a method for removing contaminants from biological fluids, which comprises the steps of: The method includes contacting the biological fluid with a crosslinked hydrophobic polymer network that coats, but is not covalently bonded to, the intercalators, the hydrophobic network substantially filling the internal void volume, thereby removing hydrophobic and amphipathic molecules having an average molecular mass of less than 10,000 Da.
[0013] US Patent No. 6,783,962 (B1) relates to a particulate material useful for the isolation / purification of biopolymers, the particulate material having a density of at least 2.5 g / mL, the particles of the particulate material having an average diameter of 5-75 μm, the particles of the particulate material consisting essentially of a polymeric base matrix and a non-porous core material, the core material having a density of at least 3.0 g / mL. The polymeric base matrix contains side groups that are positively charged at pH 4.0 or that are affinity ligands for biomolecules.
[0014] WO 2004 / 073843 discloses a composite material comprising a support member having a plurality of pores and a crosslinked gel having macropores filling the pores of the support member. A process for adsorbing biological molecules or biological ions from a liquid is also disclosed, which comprises passing a liquid containing the biological molecules or biological ions through a composite material having binding sites on the macroporous gel that specifically interact with the biomolecules.
[0015] European Patent Application Publication No. 2545989(A) discloses a composite material for chromatography applications, comprising a porous support and a crosslinked polymer on the surface of the porous support, wherein the ratio of the pore size [nm] of the porous support and the crosslinking degree [%] of the crosslinked polymer is 0.25-20 [nm / %], and the crosslinking degree based on the total number of crosslinkable groups in the crosslinked polymer is 5-20%.
[0016] WO 2018 / 050849 discloses the preparation of a composite material comprising porous silica gel with a pore size of 25 nm and cross-linked poly(vinylformamide-co-polyvinylamine).
[0017] WO 2006 / 015495 relates to a composite material comprising a porous support member filled or coated with a durable non-crosslinked polymer. The pore size of the porous support may be in the range of 0.1-5 μm. The composite material may be used for the adsorption of proteins. This reference does not mention or suggest covalently attaching a non-crosslinked polymer to the outer surface of the polymer-filled porous support.
[0018] WO 2005 / 120701 discloses a composite material comprising a support member having a plurality of pores extending therethrough and a crosslinked gel having macropores located within and filling the pores of the support member, the crosslinked gel entrapping a substantially water-insoluble but water-swellable stabilizing polymer.
[0019] EP 2027921(A) describes a porous sorptive medium comprising a substrate having a first outer surface and a second outer surface and a porous thickness therebetween, the substrate being porous on both sides, the substrate having a solid matrix of the substrate and a sorptive material substantially covering the first and second outer surfaces, the sorptive material comprising a crosslinked polymer having primary amine groups attached thereto.
[0020] WO 2011 / 140406 discloses a porous sorptive medium comprising mixed cellulose esters supported on a nonwoven substrate and coated with a crosslinked polymer having attached primary amine groups.
[0021] The present invention is designed to overcome the limitations of existing techniques in the purification of biomolecules. Summary of the Invention [Problem to be solved by the invention]
[0022] It is an object of the present invention to provide a composite material that improves the purification of proteins, such as mAbs, from biological feedstocks that contain the proteins. [Means for solving the problem]
[0023] The object of the present invention is achieved by a composite material as claimed in the attached claim 1.
[0024] Specifically, the present invention provides: A porous support having an average pore size of 5 to 500 nm, the porous support being filled with a crosslinked first polymer; a second uncrosslinked polymer covalently bonded to the outer surface of the crosslinked polymer-filled porous support; A composite material comprising:
[0025] The present invention is based on the surprising discovery that the presence of a second, uncrosslinked polymer significantly enhances the purification capabilities of a composite material compared to a composite material consisting solely of a porous support filled with a crosslinked polymer.
[0026] The present invention provides a composite material for purifying a protein of interest from undesired compounds contained in a solution or suspension, which is particularly suitable for the efficient removal of impurities from produced biopharmaceuticals, such as mAbs, and can be easily integrated into clarification and downstream purification steps (DSP).
[0027] The composite material of the present invention is preferably capable of simultaneously depleting DNA and HCPs from a protein-containing solution obtained during protein production, while also achieving a very high protein recovery rate.
[0028] The present invention also provides a) immersing a porous support having an average pore size of 5 to 500 nm in a solution or dispersion containing a first polymer, a crosslinker and a solvent; b) crosslinking the first polymer with a crosslinking agent at a temperature of less than 250° C.; and c) covalently bonding a second polymer to the outer surface of the composite material obtained in step b). The present invention also relates to a method for producing a composite material, comprising:
[0029] Further provided is the use of the composite material of the invention for purifying a protein of interest in a feedstock.
[0030] The present invention further provides a method for purifying a protein of interest in a feedstock, comprising the steps of: i) contacting a feedstock with a composite material of the present invention for a sufficient period of time; ii) separating the composite material from the refined feedstock; iii) optionally isolating the purified protein of interest from the feedstock; and iv) optionally washing the composite material with a solvent and recovering the resulting solution for further processing. The present invention provides a method comprising: DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0031] composite material As used herein, the terms "composite," "composite material," and "adsorbent" are used interchangeably. will be done.
[0032] In this specification, whenever "pore size" is mentioned, it means "average pore size".
[0033] The average pore size of the porous support material is 5 nm to 500 nm. In combination with any of the above or below described embodiments, the average pore size is preferably 15 nm to 300 nm, more preferably 20 nm to 200 nm, even more preferably 25 nm to 250 nm, even more preferably 30 nm to 200 nm, and most preferably 40 nm to 100 nm, for example, 50 nm to 100 nm. The average pore size of the porous support material in this specification is determined by mercury intrusion according to DIN 66133.
[0034] The porous support material may be a membrane, a hollow fiber, a nonwoven fabric, a monolithic material or a particulate material. Particulate and monolithic porous materials are preferred. In a preferred embodiment in combination with any of the above or below embodiments, the porous support material is a particulate porous support material having an irregular or spherical shape.
[0035] In a further preferred embodiment in combination with any of the above or below embodiments, the porous support material consists of a metal oxide, a semi-metal oxide, a ceramic material, a zeolite or a natural or synthetic polymeric material.
[0036] In a further preferred embodiment in combination with any of the above or below embodiments, the porous support material is porous silica, alumina or titania particles.
[0037] In a further preferred embodiment in combination with any of the above or below embodiments, the porous support material is porous silica gel.
[0038] In a further preferred embodiment in combination with any of the above or below embodiments, the porous support material is a porous polysaccharide, such as cellulose, chitosan, agarose, etc.
[0039] In a further preferred embodiment in combination with any of the above or below embodiments, the porous support material is a porous synthetic polymer, such as polyacrylate, polymethacrylate, polyetherketone, polyalkymether, polyarylether, polyvinyl alcohol or polystyrene, or mixtures or copolymers thereof.
[0040] In a further preferred embodiment in combination with any of the above or below embodiments, the porous support material is a particulate material having an average particle size (diameter) of 1 μm to 500 μm, preferably between 20 μm and 200 μm, more preferably between 30 and 150 μm, and most preferably between 35 and 100 μm.
[0041] The average particle size (diameter) and particle size distribution of the porous support herein are measured according to the method of Malvern It is determined by laser diffraction.
[0042] As used herein, unless otherwise specified, the term "first polymer" refers to the polymer before crosslinking.
[0043] The first polymer (i.e., before crosslinking) is not limited in any way, but preferably has a hydroxyl (-OH), thiol (-SH), carboxyl (-COOH), sulfonyl (-SO 3 H), amino or a combination thereof.
[0044] In a preferred embodiment in combination with any of the above or below embodiments, the first polymer comprises hydroxyl groups, more preferably the first polymer is poly(vinyl alcohol), agarose or cellulose.
[0045] In a preferred embodiment in combination with any of the above or below embodiments, the first polymer comprises carboxyl groups, more preferably the first polymer is a poly(meth)acrylate.
[0046] In a preferred embodiment in combination with any of the above or below embodiments, the first polymer comprises amino groups, preferably is a polyamine. In a further preferred embodiment in combination with any of the above or below embodiments, the polyamine comprises primary and / or secondary amino groups.
[0047] In a preferred embodiment in combination with any of the above or below embodiments, the first polymer is a polyamine selected from polyallylamine, polyvinylamine, polybutylamine, polylysine, and copolymers thereof.
[0048] In a preferred embodiment in combination with any of the above or hereinafter described embodiments, the first polymer is polyvinylamine or polyallylamine. Polyvinylamine and polyallylamine include linear or branched homopolymers of vinylamine or allylamine and copolymers of vinylamine or allylamine with amino or amide groups. In a further preferred embodiment in combination with any of the above or hereinafter described embodiments, the polyvinylamine is a linear or branched homopolymer of vinylamine or a copolymer of vinylamine and vinylformamide. Preferably, the copolymer of vinylamine and vinylformamide contains 1% to 70% vinylformamide units, more preferably 2% to 40% vinylformamide units, and most preferably 5% to 25% vinylformamide units, based on the total number of structural units of the polymer. In a further preferred embodiment in combination with any of the above or hereinafter described embodiments, the polyallylamine is a linear or branched homopolymer of allylamine or a copolymer of allylamine and allylformamide. Preferably, the copolymer of allylamine and allylformamide contains 1% to 70% allylformamide units, more preferably 2% to 40% allylformamide units, and most preferably 5% to 25% allylformamide units, based on the total number of structural units of the polymer.
[0049] In a preferred embodiment in combination with the above or below described embodiments, the weight average molecular weight (Mw) of the first polymer is 2,000 to 500,000 Da, preferably 10,000 to 450 Da, more preferably 15,000 to 400,000 Da, even more preferably 20,000 to 300,000 Da, and most preferably 25,000 to 250,000 Da.
[0050] Herein, the weight average molecular weight (Mw) of a polymer is determined by size exclusion chromatography (SEC) coupled with multi-angle light scattering and differential refractive index detection (SEC-MALS-RI).
[0051] In a preferred embodiment in combination with the above or below described embodiments, the first polymer is a polyvinylamine or polyallylamine having a degree of hydrolysis of formamide groups of at least 50%, preferably 60% to 99%, more preferably 66% to 94%, even more preferably 68% to 90%, and most preferably 70% to 86%.
[0052] The term "degree of hydrolysis" in this specification refers to the "degree of hydrolysis of the formamide groups of the polymer."
[0053] In a further preferred embodiment in combination with the above or below described embodiments, the first polymer is a polyvinylamine or polyallylamine having a weight average molecular weight (Mw) of 15,000 to 80,000 Da, preferably 20,000 to 70,000 Da, more preferably 25,000 to 50,000 Da, and a degree of hydrolysis of formamide groups of 66% to 99%, preferably 67% to 90%, more preferably 68% to 80%, and most preferably 68% to 75%.
[0054] In a further preferred embodiment in combination with the above or below described embodiments, the first polymer is a polyvinylamine or polyallylamine having a weight average molecular weight (Mw) of 100,000 to 500,000 Da, preferably 150,000 to 400,000 Da, more preferably 200,000 to 300,000 Da, and a degree of hydrolysis of 70% to 99%, preferably 75% to 95%, more preferably 75% to 90%.
[0055] The degree of hydrolysis of the formamide group of the polymer in this specification is measured according to the following method. 1 Determined by H-NMR: 5.25 g of polymer is weighed into a flask and 10 mL of water is added. The resulting mixture is swirled to obtain a homogeneous mixture and evaporated under vacuum at 50° C. until a dry solid is observed. The solid is dried in an oven at 80° C. under high vacuum (≦0.1 mbar) for 15 hours to obtain a dry residue.
[0056] The degree of hydrolysis is 1 H-NMR (400 MHz instrument from Brucker, solvent: D 2 O) is determined based on the quantification of hydrolyzed groups relative to the total hydrolyzable groups according to the methods described in the references.
[0057] Q. Wen, AMVincelli, R. Pelton, “Cationic polyvinylamine binding to anionic microgels yields kinetically controlled structures”, J Colloid Interface Sci. 369 (2012) 223-230.
[0058] In a further preferred embodiment in combination with the above or later described embodiments, the first polymer is crosslinked to a degree of crosslinking of 5 to 25%. In a preferred embodiment in combination with the above or later described embodiments, the degree of crosslinking is 6 to 15%, preferably 7 to 12%, more preferably 8 to 9%.
[0059] "Degree of crosslinking" is defined herein as the ratio of crosslinker / polymer (also referred to as "crosslinker ratio"), which is defined as the percentage of moles of crosslinker to vinylamine structural units (based on average molecular weight) present in the polymer solution used in the reaction.
[0060] That is, the crosslinker ratio is calculated according to the following formula (1):
[0061]
number
[0062] (where V1 (ml) is the volume of the crosslinker, d1 (g / ml) is the density of the crosslinker, C1 (wt%) is the concentration of the crosslinker, W2 (g) is the weight of the polymer solution, and C2 (wt%) is the concentration of the polymer. where Mw1 (g / mol) is the molecular weight of the crosslinker, and Mw2 (g / mol) is the average molecular weight of the monomer units.
[0063] Mw2 is calculated according to the following formula (2):
number
[0064] The second polymer is not limited in any way, but preferably has a hydroxyl (-OH), thiol (-SH), carboxyl (-COOH), sulfonyl (-SO 3 H), amino or a combination thereof.
[0065] In a preferred embodiment in combination with the above or below embodiments, the second polymer comprises hydroxyl groups, more preferably the second polymer is poly(vinyl alcohol), agarose or cellulose.
[0066] In a preferred embodiment in combination with the above or below embodiments, the second polymer comprises a carboxyl group, more preferably the second polymer is a poly(meth)acrylate.
[0067] In a preferred embodiment in combination with any of the above or below embodiments, the second polymer comprises amino groups, preferably is a polyamine. In a further preferred embodiment in combination with any of the above or below embodiments, the polyamine comprises primary and / or secondary amino groups.
[0068] In a preferred embodiment in combination with the above or below embodiments, the second polymer is a polyamine selected from polyallylamine, polyvinylamine, polybutylamine, polylysine, and copolymers thereof.
[0069] In a preferred embodiment in combination with any of the above or below embodiments, the second polymer is a polyvinylamine or polyallylamine, including linear or branched homopolymers of vinylamine or allylamine and copolymers of vinylamine or allylamine with amino or amide groups.
[0070] In a further preferred embodiment in combination with any of the above or below embodiments, the polyvinylamine is a linear or branched homopolymer of vinylamine or a copolymer of vinylamine and vinylformamide. Preferably, the copolymer of vinylamine and vinylformamide contains 1% to 70% vinylformamide units, based on the total number of structural units of the polymer, more preferably 2% to 40% vinylformamide units, most preferably 5% to 25% vinylformamide units.
[0071] In a further preferred embodiment in combination with any of the above or below embodiments, the polyallylamine is a linear or branched homopolymer of allylamine or a copolymer of allylamine and allylformamide. Preferably, the copolymer of allylamine and allylformamide contains 1% to 70% allylformamide units, more preferably 2% to 40% allylformamide units, and most preferably 5% to 25% allylformamide units, based on the total number of structural units of the polymer.
[0072] In a preferred embodiment in combination with any of the above or below described embodiments, the weight average molecular weight (Mw) of the second polymer is at least 15,000 Da, preferably 20,000 to 1,000,000 Da, more preferably 25,000 to 500,000 Da, even more preferably 30,000 to 300,000, even more preferably 50,000 to 300,000 Da, and most preferably 80,000 to 250,000 Da.
[0073] In a preferred embodiment in combination with any of the above or below described embodiments, the second polymer is a polyvinylamine or polyallylamine having a degree of hydrolysis of formamide groups of at least 50%, preferably between 60% and 99%, more preferably between 66% and 94%, even more preferably between 68% and 90%, and most preferably between 70% and 86%.
[0074] In a further preferred embodiment in combination with any of the above or below described embodiments, the second polymer is a polyvinylamine or polyallylamine having a weight average molecular weight (Mw) of 15,000 to 80,000, preferably 20,000 to 70,000, more preferably 25,000 to 50,000, and a degree of hydrolysis of 66% to 99%, preferably 67% to 90%, more preferably 68% to 80%, and most preferably 68% to 75%.
[0075] In a further preferred embodiment in combination with any of the above or below described embodiments, the second polymer has a weight average molecular weight (Mw) of 100,000 to 500,000, preferably 150,000 to 400,000, more preferably 200,000 to 300,000, and a degree of hydrolysis of 70% to 99%, preferably 75% to 95%, more preferably 75% to 90%.
[0076] In a preferred embodiment in combination with any of the above or below embodiments, the first polymer has an equal weight average molecular weight (Mw) to the second polymer.
[0077] In a preferred embodiment in combination with any of the above or below embodiments, the first polymer (i.e. before crosslinking) is identical to the second polymer.
[0078] In another preferred embodiment in combination with any of the above or below embodiments, the weight average molecular weight (Mw) of the second polymer is greater than the weight average molecular weight (Mw) of the first polymer.
[0079] In a further preferred embodiment in combination with any of the above or below described embodiments, the weight average molecular weight (Mw) of the first polymer is 10,000 to 100,000, preferably 15,000 to 50,000, more preferably 20,000 to 30,000, and the weight average molecular weight (Mw) of the second polymer is 100,000 to 500,000, preferably 150,000 to 300,000, more preferably 200,000 to 250,000.
[0080] In a preferred embodiment in combination with any of the above or below embodiments, the total concentration of the first polymer and the second polymer is at least 3% w / w, preferably at least 5% w / w, more preferably at least 7% w / w, and preferably less than 25% w / w, more preferably less than 20% w / w, most preferably less than 15%, based on the total weight of the dry composite material.
[0081] The composite material of the present invention may include an additional layer of an uncrosslinked polymer, said uncrosslinked polymer being covalently bonded to the porous support filled with the crosslinked polymer and / or to a second uncrosslinked polymer.
[0082] In a preferred embodiment in combination with any of the above or below embodiments, the composite material comprises 1 to 3 additional layers of uncrosslinked polymer, which may be the same or different from the second polymer, said additional layers of uncrosslinked polymer should be covalently bonded to each other and to the porous support filled with crosslinked polymer and / or to the second polymer.
[0083] In another preferred embodiment in combination with any of the above or below embodiments, the composite does not include an additional layer of uncrosslinked polymer (i.e. the only polymers present in the composite are the first polymer and the second polymer).
[0084] Manufacturing method for composite materials The composite material of the present invention can be produced according to the following method: a) immersing a porous support having an average pore size of 5 to 500 nm in a solution or dispersion containing a first polymer, a crosslinker, and a solvent; b) crosslinking the first polymer with a crosslinking agent at a temperature less than 250°C; c) covalently bonding a second polymer to the outer surface of the composite material obtained in step b).
[0085] Any crosslinker having at least two reactive groups can be used in the present invention.
[0086] In a preferred embodiment in combination with any of the above or below embodiments, the crosslinking agent is selected from bisepoxides, dialdehydes and diglycidyl ethers. In a more preferred embodiment in combination with any of the above or below embodiments, the crosslinking agent is selected from propanediol diglycidyl ether, butanediol diglycidyl ether, hexanediol diglycidyl ether, polyethylene glycol diglycidyl ether, glutaric dialdehyde and succinic dialdehyde. More preferably, the crosslinking agent is selected from butanediol diglycidyl ether and hexanediol diglycidyl ether.
[0087] If the first polymer does not contain crosslinkable groups, prior to step a) of the above method, the first polymer is functionalized with crosslinkable groups by any method known in the art.
[0088] In a preferred embodiment in combination with any of the above or below described embodiments, the crosslinker ratio is 6-15% (mol / mol), more preferably 7-12% (mol / mol), most preferably 8-9% (mol / mol).
[0089] Any solvent or medium capable of dissolving or dispersing the polymer and the crosslinker can be used, provided that it does not react or only slowly reacts with the crosslinker and the polymer under the conditions of step b) of the above-mentioned method, slowly in this context means that no observable reaction occurs between the crosslinker and the solvent, and between the polymer and the solvent, during the course of step b).
[0090] In a preferred embodiment in combination with any of the above or below embodiments, the solvent is a polar protic solvent or a polar aprotic solvent. In a preferred embodiment in combination with any of the above or below embodiments, the solvent is water, C 1 ~ 6 A polar protic solvent selected from alcohols (e.g., methanol, ethanol, isopropanol and butanol) and mixtures thereof. Water is most preferred.
[0091] In a preferred embodiment in combination with any of the above or below embodiments, the pH of the solution of polymer and crosslinker used in step a) is between 8 and 13, preferably between 9 and 11, most preferably between 10 and 12. The pH is preferably adjusted to 10 to 11. The pH can be adjusted by adding a strong base such as NaOH or KOH.
[0092] The temperature at which step b) of the above-mentioned method is carried out is preferably 20 to 180°C, more preferably 40 to 100°C, and most preferably 50 to 80°C.
[0093] In a preferred embodiment in combination with any of the above or below described embodiments, the time for carrying out step b) is preferably from 1 hour to 100 hours, more preferably from 8 hours to 60 hours, most preferably from 18 hours to 48 hours.
[0094] In a further preferred embodiment in combination with any of the above or below embodiments, step b) is carried out at 40-100°C for 8-60 hours, preferably at 50-80°C for 12-50 hours, more preferably at 60°C for 24-48 hours.
[0095] The covalent attachment of the second polymer to the outer surface of the composite material obtained in step b) can be achieved by any means known in the art. The reaction that takes place on the outer surface of the composite material obtained in step b) can include polymerization or any grafting-from method and any grafting-to method.
[0096] In a further preferred embodiment in combination with any of the above or below embodiments, the second polymer is dissolved in a suitable solvent or medium. Any solvent capable of dissolving the second polymer can be used, provided that it does not react or only reacts slowly with the polymer under the conditions of step c) of the above method. In this context, slowly means that no observable reaction occurs between the second polymer and the solvent during the carrying out of step c).
[0097] In a preferred embodiment in combination with any of the above or below embodiments, the solvent for the second polymer is a polar protic solvent or a polar aprotic solvent. In a preferred embodiment in combination with any of the above or below embodiments, the solvent for the second polymer is water, C 1 ~ 6 A polar protic solvent selected from alcohols (e.g., methanol, ethanol, isopropanol and butanol) and mixtures thereof. Water is most preferred.
[0098] In a preferred embodiment in combination with any of the above or below described embodiments, the pH of the second polymer-containing solution that can be used in step c) is adjusted to 8 to 13, preferably 9 to 11, most preferably 10 to 11. The pH adjustment can be carried out by adding a strong base such as NaOH or KOH.
[0099] In a preferred embodiment in combination with any of the above or below embodiments, the covalent attachment of the second polymer to the outer surface of the composite material obtained in step b) is achieved via the crosslinker still present on the outer surface of the composite material obtained in step b).
[0100] The term "uncrosslinked polymer" as used herein refers to a polymer that has not had a crosslinking agent added to it to activate crosslinking. Thus, for embodiments in which a second polymer is dissolved in a solvent, the solvent does not include a crosslinking agent.
[0101] In a further preferred embodiment in combination with any of the above or below embodiments, the method further comprises, after step c), a step d) of hydrolyzing unreacted crosslinkable groups of the crosslinker.
[0102] Use of composite materials In this specification, the terms "feedstock" and "feed" are used interchangeably.
[0103] As used herein, the term "protein" includes polypeptides. This type of polypeptide preferably contains at least 20 amino acid residues, more preferably 40 to 80 amino acid residues.
[0104] The composite material of the present invention is useful for the purification of a protein of interest in a feedstock.
[0105] In a preferred embodiment in combination with any of the above or below embodiments, the feedstock comprises host cell derived proteins (HCPs) and DNA, and optionally RNA and other nucleic acids.
[0106] The feedstock in the present invention optionally includes albumin, endotoxin, detergent and microorganisms or fragments thereof.
[0107] The present invention also provides a method for purifying a protein of interest in a feedstock, comprising the steps of: i) contacting the feedstock with a composite material according to the present invention for a sufficient period of time; ii) separating the composite material from the refined feedstock; iii) optionally isolating the purified protein of interest from the feedstock; and iv) optionally washing the composite material with a solvent and recovering the resulting solution for further processing.In a preferred embodiment in combination with any of the above or below embodiments, the protein of interest is a recombinant protein such as a monoclonal antibody (mAb) (e.g., human immunoglobulin (hIgG)).
[0108] In a preferred embodiment in combination with any of the above or below embodiments, the feed solvent is water, optionally containing buffers, salts and / or modifiers.
[0109] In a preferred embodiment in combination with any of the above or below embodiments, the feedstock is a fermentation broth supernatant (before or after filtration) or cell culture supernatant (CCS) containing the protein of interest and DNA, RNA or other nucleic acids as well as host cell proteins (HCPs) as impurities.
[0110] In a preferred embodiment in combination with any of the above or below embodiments, the composite material is used in a batch adsorption process, in which in step i) of the purification method of the invention the composite material is dispersed in a feedstock and in step ii) the composite material is separated from the feedstock (for example by centrifugation).
[0111] In another preferred embodiment in combination with any of the above or below embodiments, the composite material is packed in a chromatography column.
[0112] In the method for recovering a target protein of the present invention, the feedstock is contacted with the composite material of the present invention for a sufficient period of time. In a preferred embodiment in combination with any of the embodiments described below, the contact time is 1 minute to 10 hours, preferably 3 minutes to 5 hours, and more preferably 5 minutes to 1 hour.
[0113] In a preferred embodiment in combination with any of the above or below embodiments, the composite material is treated with a pH of less than 8, preferably between 3 and 7.5, prior to contacting the composite material with the feedstock. More preferably, equilibration is performed in an aqueous solution having a pH of 4 to 7, and most preferably 5 to 6. The pH of the aqueous solution can be adjusted by any suitable buffer. For example, a monobasic acid or a salt thereof can be used to adjust the pH. Preferred monobasic acids are formic acid, acetic acid, sulfamic acid, hydrochloric acid, perchloric acid, and glycine. Preferred salts of monobasic acids are ammonium, alkylammonium, sodium, and potassium salts.
[0114] In a preferred embodiment in combination with any of the above or below embodiments, the pH is adjusted using ammonium acetate.
[0115] In a further preferred embodiment in combination with any of the above or below embodiments, the pH is adjusted with phosphate buffered saline (PBS).
[0116] In a preferred embodiment in combination with any of the above or below described embodiments, the feedstock to composite ratio (volume of feed to weight of dry composite) is in the range of 2:1 to 100:1, preferably 5:1 to 80:1, more preferably 10:1 to 70:1, most preferably 20:1 to 50:1. A higher feedstock to composite ratio is preferred in terms of efficient utilization of the composite.
[0117] In a preferred embodiment in combination with any of the above or below embodiments, the composite material comprising adsorbed impurities, separated in step ii) of the above method, is subjected to an elution procedure for eluting said impurities, thereby regenerating the composite material for further use.
[0118] The purification method of the protein of interest of the present invention may include further purification steps known in the art, examples of such purification steps include ion exchange chromatography, addition of flocculants or precipitants, centrifugation, crystallization, affinity chromatography (e.g., using a separation medium containing Protein A, Protein G or a combination thereof), membrane filtration, depth filtration (using diatomaceous earth or activated carbon) and application of monolithic separation agents.
[0119] In a preferred embodiment in combination with any of the above or below mentioned embodiments, steps i) and ii) of the method for isolating a protein of interest of the invention are repeated several times (e.g. 2, 3, 4, 5, 6 times) in succession using the same or different composite materials according to the invention.
[0120] The following examples illustrate the invention. EXAMPLES
[0121] Starting materials used in the examples The following starting materials were used in the preparation of the example composites: polymer: A1 Lupamin 4570 (supplied by BASF) (copolymer of vinylamine and vinylformamide) A2 Lupamin 4570 further hydrolyzed to a degree of hydrolysis of 68% A3 Lupamin 4570 further hydrolyzed to a degree of hydrolysis of 86% A4 Lupamin 4570 further hydrolyzed to a degree of hydrolysis of 99% A5 Lupamin 9095 (supplied by BASF) (copolymer of vinylamine and vinylformamide) A6 Lupamin 9095 further hydrolyzed to a degree of hydrolysis of 99% A7 Lupamin 4500 (supplied by BASF) (copolymer of vinylamine and vinylformamide) A8 Lupamin 4500 further hydrolyzed to a degree of hydrolysis of 23% A9 Lupamin 9030 (supplied by BASF) (copolymer of vinylamine and vinylformamide) A10 Poly(allylamine hydrochloride) (supplied by Sigma-Aldrich) Polymers A2 to A4, A6 and A8 were obtained by further hydrolyzing polymers A1, A5 and A7 as shown below.
[0122] Polymer A1, A5, or A7 was homogenized by gentle stirring on a rotating table. The homogenized polymer was weighed into a round-bottom flask, and the mixture was stirred at 80° C. for several hours with an aqueous solution of sodium hydroxide in N 2 Heating was performed under protection of airflow. The mixture was then cooled to room temperature (23° C.) and the pH was adjusted using hydrochloric acid solution. The exact conditions are listed in Table 1.
[0123] [Table 1]
[0124] The properties of polymers A1 to A10 are shown in Table 2 below.
[0125] [Table 2]
[0126] 1) Degree of hydrolysis The degree of hydrolysis of formamide groups in polymers A1 to A9 is shown below. 1 H-NMR was used for the measurement.
[0127] Polymer samples for NMR analysis were prepared according to the following general procedure: 5.25 g of commercial polymer or further hydrolyzed polymer was weighed into a flask and 10 mL of water was added. The mixture was swirled to obtain a homogeneous composition and evaporated under vacuum at 50° C. to obtain a dry solid. The solid was dried in an oven at 80° C. under high vacuum (≦0.1 mbar) for 15 hours to obtain a dry residue.
[0128] 1 The degree of hydrolysis was determined based on the quantification of free amine groups relative to formamide groups by H-NMR according to the method described in reference: Q. Wen, AMVincelli, R. Pelton, “Cationic polyvinylamine binding to anionic microgels yields kinetically controlled structures”, J Colloid Interface Sci. 369 (2012) 223-230.
[0129] Used for measurement 1 The H-NMR system was 400 MHz. The dried samples were 2 Dissolved in O.
[0130] 2) Polymer concentration The polymer concentrations of polymers A1 to A10 were determined based on elemental analysis. 1 The same procedure as described in the H-NMR section was used for preparation and carried out until a dry residue was obtained. The elemental analyzer was a FLASH 2000 Organic Elemental Analyzer (Thermo Scientific).
[0131] 3) Weight average molecular weight (Mw), polydispersity (Mw / Mn) and specific refractive index increment (dn / dc) of the polymer The weight average molecular weight (Mw), polydispersity (Mw / Mn) and specific refractive index increment (dn / dc) of the polymer were determined as follows:
[0132] Size-exclusion chromatography (SEC) coupled with multi-angle light scattering and refractive index detection (SEC-MALS-RI) was used and the weight-average molecular weight (Mw) was determined using the Rayleigh-Gans-Debye equation in its Zimm form.
[0133] In this approach, it is assumed that the light scattering signal is proportional to the average molecular weight at any point in the chromatogram and the sample concentration and the specific refractive index increment (dn / dc). Thus, a light scattering detector coupled with a refractive index detector as a concentration detector can accurately determine the average molecular weight at any point in the chromatogram, and once the value of dn / dc is obtained, analysis of the entire chromatographic distribution can be used to determine the weight average molecular weight (Mw).
[0134] In the Rayleigh-Ganz-Debye equation (Equation (1)), the light scattering signal is proportional to the average molecular weight and sample concentration and the specific refractive index increment (dn / dc) at any point in the chromatogram. R(θ)=K * MCP(θ)[1-2A 2 MCP(θ)] (1) In equation (1), R(θ) is the excess (relative to the solute alone) Rayleigh ratio (i.e., the ratio of scattered and incident light intensities corrected for the scattering volume and distance from the scattering volume), M is the molar mass (molecular weight), C is the concentration of the analyte, and K * is the Rayleigh ratio constant defined according to equation (2): K * =(4π 2 (n 0 ) 2 / N A (λ 0 ) 4 )(dn / dc) (2) In formula (2), n 0 is the refractive index of the solvent, N A is Avogadro's constant, λ 0 is the vacuum wavelength of the incident light, dn / dc is the specific refractive index increment, P(θ) is the shape factor or scattering function, and the mean square radius of the particle (r g ) is related to the angular variation of the scattering intensity with respect to the angle, A 2 is the second virial coefficient, which is a measure of the solute-solvent interaction.
[0135] From this analysis, the number average molecular weight (Mn), weight average molecular weight (Mw), polydispersity (Mw / Mn) and peak molecular weight (Mp) can be determined.
[0136] Measuring equipment: The SEC / MALS / RI system consisted of a Shimadzu LC 20A system, a Wyatt Optilab rEX RI detector and a Wyatt DAWN HELEOS-II MALS detector.
[0137] Molecular weights (Mw and Mn) and polydispersity (Mw / Mn) were calculated using Astra (version: 5.3.4.20) software from Wyatt.
[0138] To perform the SEC analysis of the polymers, a Tosoh TSKgel G3000PWxL (7 μm, 7.8 mm I.D. × 30 cm) equipped with a precolumn Tosoh TSKgel G6000PWxL (13 μm, 7.8 mm I.D. × 30 cm) was used.
[0139] Analysis conditions: Mobile phase: 0.45M aqueous sodium nitrate solution + 0.5% (v / v) trifluoroacetic acid (TFA) Flow rate: 0.5mL / min detection: MALS linearly polarized laser wavelength: 658 nm RI Temperature: 25℃ Injection volume: 50μL Sample dilution: 10 mg of polymer (concentration shown in Table 2) diluted with 1.5 mL of mobile phase Driving time: 58 min
[0140] Porous support: B1 Silica gel Davisil LC 250, 40-63 μm (supplied by W.R. Grace) B2 Silica gel XWP500A, 35-75μm (supplied by WRGrace) B3 Silica gel XWP1000A, 35-75μm (supplied by WRGrace)
[0141] The properties of the porous supports B1 to B3 are shown in Table 3 below.
[0142] [Table 3]
[0143] The pore size of the porous support was determined by mercury intrusion in accordance with DIN 66133.
[0144] The particle size distribution of the porous support was determined by Malvern Laser Diffraction.
[0145] Crosslinker: 1,6-Hexanediol diglycidyl ether (HDGE; ipox RD18 supplied by Ipox Chemicals) 1,4-Butanediol diglycidyl ether (BDGE; supplied by Sigma-Aldrich, and ipox RD3 supplied by Ipox Chemicals)
[0146] Example 1: Process 1 By mixing 15 mL of an aqueous solution of polymer A2 (11% solution of polymer A2) with a solution of 1,6-hexanediol diglycidyl ether (HDGE) (704 μL), The crosslinker was adjusted to 7-9%. The crosslinker ratio was calculated taking into account the amount of reactive groups relative to the vinylamine units present in the polymer solution used in the reaction. After mixing, the pH was adjusted to 11 using 0.5 M NaOH.
[0147] 10 g of the dry powdered porous support B1 was placed in a flat-bottomed stainless steel dish with a diameter of 8 cm. 39.5 g of the polymer-crosslinker solution was dripped evenly over the entire porous support and stirred with a spatula. The resulting paste was shaken at 600 rpm for 1 minute on a gyratory shaker to obtain a smooth, homogenous mass. The dish was then covered with a stainless steel lid and the paste was heated in an oven at 60° C. for 24 hours without further mixing or agitation to obtain a wet composite.
[0148] Process 2 1.3 mL of 0.5 M NaOH was added to 6.3 g of an aqueous solution of polymer A5 (7% solution of polymer A5). After mixing, 17 mL of water was added to the solution to constitute the polymer A5 solution used in the next synthetic step.
[0149] A 29 g portion of the wet composite prepared in step 1 was taken and washed 4 times with 25 mL of water on a frit. The composite cake was then suspended in 22 mL of Polymer A5 solution in an Erlenmeyer flask and shaken at 60° C. for 24 hours.
[0150] The wet paste was then washed on the frit with 25 mL of water three times. The composite cake was then suspended in 20 mL of 10% sulfuric acid and treated in a shaker bath for 2 hours at ambient temperature (23°C) to terminate (hydrolyze) the unreacted epoxy groups. The product was then washed again on the frit six times with 25 mL of water, and then stored in 20% ethanol water.
[0151] Examples 2 to 10: Examples 2-10 were prepared similarly to Example 1, except that the starting materials and crosslinker ratios were as listed in Table 4.
[0152] The amount of polymer in step 1 was adjusted to take into account the pore size and surface area of the porous support, taking into account that not all of the silica loaded has the same pore volume. For the examples presented here, the amount of second polymer added to the wet composite in step 2 (polymer to silica weight ratio) was kept constant.
[0153] [Table 4]
[0154] To demonstrate the advantage of covalently attaching a second polymer to the outer surface of a composite formed from a porous support filled with a crosslinked polymer, a composite composed of a porous support filled with a crosslinked polymer was prepared as follows.
[0155] Comparative Example 1: 15 mL of an aqueous solution of polymer A1 (15% solution of polymer A1) was mixed with a solution of 1,6-hexanediol diglycidyl ether (HDGE) (704 μL) to give a crosslinker concentration of 7-9%. The crosslinker ratio was calculated taking into account the amount of reactive groups relative to the vinylamine units (monomers) present in the polymer solution used for the reaction. After mixing, the pH was adjusted to 11 using 0.5 M NaOH.
[0156] 10 g of dry powdered porous support B1 was placed in a flat-bottomed stainless steel dish with a diameter of 8 cm. 39.5 g of the polymer-crosslinker solution was dripped evenly onto the porous support to impregnate the porous support B1 and mixed with a spatula. The resulting paste was shaken on an orbital shaker at 600 rpm for 1 minute to obtain a smooth, homogenous mass. The dish was then covered with a stainless steel lid and the paste was heated in an oven at 60° C. for 48 hours without further mixing or agitation to obtain 49.6 g of wet composite.
[0157] The wet composite (41.3 g) was then washed five times with 25 mL of water on a frit. The cake was then suspended in 31.6 mL of 10% sulfuric acid and treated in a shaking thermostatic bath for 2 hours at ambient temperature (23° C.) to terminate unreacted epoxy groups. The product was then washed five times again with 25 mL of water on a frit and stored in 20% ethanol water.
[0158] Comparative Examples 2 to 7: Comparative Examples 2-7 were prepared similarly to Comparative Example 1 except that the starting materials listed in Table 5 were used.
[0159] [Table 5]
[0160] Measurement of removal performance and hIgG recovery rate of the composite material of the embodiment To measure the purification capacity of a composite material, the degree to which impurities or undesired compounds have been removed (separated) from the target substance is measured. For this purpose, the concentrations of the individual components in the feed are determined using selective assays. After the purification step, the concentration measurements are repeated on the purified fractions. From these concentrations and the corresponding volumes it is thus possible to calculate both the purity and the recovery.
[0161] supplies The feed consisted of untreated and undiluted cell culture supernatant CHO K1 spiked with 2 mg / mL of human plasma-derived hIgG (Octagam, 10% solution, Octapharma, Vienna).
[0162] Cell culture supernatant (CCS) CCS1 CHO-K1 (Invivo, Berlin) Cell line: CHO-K1 (2.5×10 6 live cells / mL) Electrical conductivity: 15mS / cm Average host cell protein (HCP) concentration: 100-150 μg / mL Average DNA concentration: 700~1,000ng / mL CCS2 CHO-K1 (Invivo, Berlin) Cell line: CHO-K1 Electrical conductivity: 13mS / cm Average host cell protein (HCP) concentration: 65-82 μg / mL Average DNA concentration: 250~500ng / mL CCS3 CHO-K1 (Invivo, Berlin) Cell line: CHO-K1 Electrical conductivity: 13mS / cm Average host cell protein (HCP) concentration: 150-200 μg / mL Average DNA concentration: 500~1,100ng / mL
[0163] All adsorbents were equilibrated with 50 mM ammonium acetate at pH 6.5 before contact with the feed.
[0164] 20 mg of sorbent was incubated with 1 mL of feed in an Eppendorf or centrifuge tube. The feed volume to sorbent weight ratio was 50:1 (1 mL feed: 0.02 g sorbent). After gentle shaking for 5 min, the supernatant was centrifuged for subsequent analysis. Contact time was 5 min unless otherwise specified.
[0165] To determine the removal efficiency of host cell proteins (HCPs) and DNA, and the recovery efficiency of hIgG, the three substances listed above were quantified in the raw feed and the depleted feed after contacting with the composite material for a specified time, and both values were then compared.
[0166] Host cell protein (HCP) measurement The Cygnus CHO HCP Elisa Kit 3G was used to determine the efficiency of removal of host cell proteins (HCPs). CHO Host Cell Proteins 3G (Cygnus Technologies, Southport, USA) rd Generation (#F550) was used according to the manufacturer's instructions (Instruction Manual "800-F550, Rev.3, 21JUL2015"), and a VictorX Spectrophotometer and corresponding software from PerkinElmer (Courtaboeuf, France) were used for reading and data evaluation. Samples were diluted with sample diluent (product catalog number #I028, purchased from Cygnus Technologies).
[0167] The HCP removal rate is expressed as follows: HCP removal rate (%) = 100 × (HCP concentration in the supernatant) / (HCP concentration in the CCS at the initial spike) In the above formula, "supernatant" refers to CCS after purification.
[0168] DNA measurements The samples analyzed were the initial CCS (with or without spiked hIgG) and the samples after the depletion treatment.
[0169] DNA was extracted using the DNA Extraction Kit (#D100T), Cygnus Technologies, Southport (USA) according to the manufacturer's instructions, and then quantified by DNA specific fluorescence assay using the Quant-iT™ PicoGreen® dsDNA Reagent Kit (#P7589), Invitrogen (Germany). A VictorX Spectrophotometer and corresponding software from PerkinElmer (Courtaboeuf, France) were used for reading and data evaluation.
[0170] The DNA removal rate is expressed as follows: DNA removal rate (%) = 100 × (DNA concentration in the supernatant) / (DNA concentration in the CCS at the initial spike) In the above formula, "supernatant" refers to CCS after purification.
[0171] hIgG recovery measurement by size exclusion chromatography (SEC) hIgG recovery was determined by quantitative SEC as follows.
[0172] The hIgG concentration in the feed and the hIgG recovery rate in the solution after purification were determined by SEC under the following conditions.
[0173] Column: TSKgel UP SW3000 4.6 × 300 mm (particle size 2 μm) from Tosoh Bioscience LCC Mobile phase: 100 mM sodium phosphate buffer (pH 6.7) + 100 mM Na 2 SO 4 +0.05% NaN 3 Injection volume: 10 μL (sample diluted with mobile phase) Flow rate: 0.35mL / min Detector: DAD 280nm Temperature: 25℃
[0174] This highly efficient column and the associated analytical conditions allow for proper quantification of the monomer and dimer peaks.
[0175] hIgG recovery was expressed as follows: Recovery rate (%) = 100 × (hIgG concentration in the supernatant) / (hIgG concentration in CCS at the time of initial spike) In the above formula, "supernatant" refers to CCS after purification.
[0176] The results are shown in Table 6.
[0177] [Table 6]
[0178] The recovery of hIgG was nearly quantitative (≧96%) for Examples 1-8 and 10, where the feed:conjugate ratio was 50:1. The recovery for Example 9 was just below 90%.
[0179] The above measurements were repeated for Examples 1-6, with a feedstock:composite ratio of 5:1.
[0180] The complexes of Examples 1-6 removed greater than 95% of the DNA and HCPs from the feedstock when the feedstock:complex ratio was 5:1.
[0181] Without wishing to be bound by any particular theory, it is believed that the majority of the hIgG remains excluded from the particles, while smaller proteins (HCPs) and DNA remain adsorbed within and around the particles.
[0182] As can be seen from Table 6, the removal performance of Example 1 and Comparative Example 2 is comparable. However, Example 2 (including a porous support having an average pore size of 500 Å) is significantly better than Comparative Example 3 (including a porous support having an average pore size of 500 Å but not including a second polymer). Similarly, Examples 4 and 6 to 8 are significantly better than Comparative Example 5 (not including a second polymer), and Examples 9 and 10 are significantly better than Comparative Examples 6 and 7, respectively. Examples 2, 3, 7, and 9, in which the weight average molecular weight (Mw) of the second polymer is larger than that of the first polymer, have particularly high DNA and HCP removal performance. Other embodiments of the present disclosure include the following. [1] A porous support having an average pore size of 5 to 500 nm and filled with a crosslinked first polymer; a second uncrosslinked polymer covalently bonded to the outer surface of the crosslinked polymer-filled porous support; Composite material comprising: [2] The composite material according to [1], wherein the first polymer is selected from polyvinylamine and polyallylamine. [3] The composite material according to [1] or [2], wherein the second polymer is selected from polyvinylamine and polyallylamine. [4] The composite material according to [2] or [3], wherein the polyvinylamine is a linear or branched homopolymer of vinylamine or a copolymer of vinylamine and vinylformamide. [5] The composite material according to any one of [2] to [4], wherein the polyvinylamine or polyallylamine has a degree of hydrolysis of formamide groups of at least 50%. [6] The composite material according to any one of [1] to [5], wherein the porous support is a particulate material having an average particle diameter of 1 to 500 μm. [7] The composite material according to any one of [1] to [6], wherein the weight average molecular weight (Mw) of the second polymer is greater than the weight average molecular weight (Mw) of the first polymer. [8] A method for producing a composite material according to any one of [1] to [7], a) immersing a porous support having an average pore size of 5 to 500 nm in a solution or dispersion containing a first polymer, a crosslinker and a solvent; b) crosslinking the first polymer with a crosslinking agent at a temperature less than 250° C.; and c) covalently bonding a second polymer to the outer surface of the composite material obtained in step b). A method comprising: [9] The method according to [8], wherein the first polymer has a weight average molecular weight (Mw) of 2,000 to 500,000 Da, and / or the second polymer has a weight average molecular weight (Mw) of at least 15,000 Da.
[10] The method according to [8] or [9], wherein the crosslinking agent is selected from propanediol diglycidyl ether, butanediol diglycidyl ether, hexanediol diglycidyl ether, glutaric dialdehyde and succinic dialdehyde.
[11] Use of the composite material according to any one of [1] to [7] for purifying a target protein in a feedstock.
[12] The use according to
[11] , wherein the target protein is a monoclonal antibody.
[13] A method for purifying a protein of interest in a feedstock, comprising: i) contacting the feedstock with the composite material according to any one of [1] to [7] for a sufficient period of time; ii) separating said composite material from the refined feedstock; iii) optionally isolating the purified protein of interest from the feedstock; and iv) optionally washing the composite material with a solvent and recovering the resulting solution for further processing. A method comprising:
[14] The method according to
[13] , wherein the target protein is a monoclonal antibody.
[15] The method according to
[13] or
[14] , wherein the contact time is at least 1 minute.
Claims
1. A porous support having an average pore size of 5 to 500 nm, the porous support being filled with a crosslinked first polymer; a second uncrosslinked polymer covalently bonded to the outer surface of the crosslinked polymer-filled porous support; A composite material comprising: the first polymer is a polyallylamine; and The composite material, wherein the second polymer is a poly(meth)acrylate.
2. The composite material according to claim 1 , wherein the porous support is a particulate material having an average particle size of 1 to 500 μm.
3. 3. The composite material of claim 1 or 2, wherein the weight average molecular weight (Mw) of the second polymer is greater than the weight average molecular weight (Mw) of the first polymer.
4. A method for producing the composite material according to any one of claims 1 to 3, comprising the steps of: a) immersing a porous support having an average pore size of 5 to 500 nm in a solution or dispersion containing a first polymer, a crosslinker and a solvent; b) crosslinking the first polymer with a crosslinking agent at a temperature less than 250° C.; and c) covalently bonding a second polymer to the outer surface of the composite material obtained in step b). A method comprising:
5. The method of claim 4, wherein the first polymer has a weight average molecular weight (Mw) of 2,000 to 500,000 Da and / or the second polymer has a weight average molecular weight (Mw) of at least 15,000 Da.
6. 6. The method according to claim 4 or 5, wherein the crosslinking agent is selected from propanediol diglycidyl ether, butanediol diglycidyl ether, hexanediol diglycidyl ether, glutaric dialdehyde and succinic dialdehyde.
7. A method for purifying a protein of interest in a feedstock according to any one of claims 1 to 3. Use of composite materials.
8. The use according to claim 7, wherein the target protein is a monoclonal antibody.
9. 1. A method for purifying a protein of interest in a feedstock, comprising: i) contacting said feedstock with the composite material of any one of claims 1 to 3 for a sufficient period of time; and ii) separating said composite material from the refined feedstock; A method comprising:
10. 10. The method of claim 9, further comprising isolating the purified protein of interest from the feedstock.
11. 11. The method of claim 9 or 10, further comprising washing the composite material with a solvent and recovering the resulting solution for further processing.
12. The method according to any one of claims 9 to 11, wherein the target protein is a monoclonal antibody.
13. The method according to any one of claims 9 to 12, wherein the contact time is at least 1 minute.
Citation Information
Patent Citations
Composite material comprising layered hydrophilic coatings
CN101048222A
Material capable of immobilizing biological substance and application thereof as carrier of affinity chromatography
JP1990090943A
Graft-modified organic porous body and its manufacturing process
JP2004331776A
Chromatography composite materials
JP2014521078A
Chromatography carrier and protein purification method using the same
JP2016006410A
